Boston University Spin-Out and Funding
The NanoView technology was spun-out from the Ünlü lab (https://www.bu.edu/eng/profile/selim-unlu/), where Dr. Freedman and Dr. Daaboul were researchers. The laboratory has a history of developing interferometric based biosensors since 2007. The laboratory received an NSF-AIR award (NSF-IIP #1127833) to develop and build the prototype NanoView platform.
NanoView has received support from the NSF through an SBIR Phase II grant (NSF-IIP #1831192). This grant allowed improvements in the NanoView technology. For more information on the the NSF seed fund program: https://seedfund.nsf.gov/
NanoView has also received support from the NIH through an SBIR Phase I grant. This grant is exploring the use of the ExoView platform for early diagnostic applications.
In October 2018 NanoView Biosciences completed a Series B financing of $10M led by Northpond Ventures. Proceeds will be used to complete development of the ExoView system, NanoView’s complete exosome detection and characterization platform, and to prepare the product for commercial launch.